About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Dallas | 219 Studies

Clinical Trials Colorectal CancerDallas

Colorectal Cancer Clinical Trials in Dallas

Find 219 clinical trials for colorectal cancer near Dallas, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 219 trials

Active not recruitingA Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsThis is a Phase 1/2 study to assess the safety and efficacy of ELI-002 7P immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus a mixture of…NCT05726864·Gilbert, Arizona and 27 others RecruitingPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerA Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus…NCT07228832·Mobile, Alabama and 242 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal CancerThis is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care…NCT04322539·Phoenix, Arizona and 152 others

Active not recruitingTesting the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT StudyThis phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch…NCT02997228·Kingman, Arizona and 444 others

RecruitingA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)This study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell…NCT06330064·Los Angeles, California and 119 others

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

TerminatedA Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal CancerThis is a randomized, open-label, dose/schedule optimization study comparing NUC-3373/leucovorin (LV)/irinotecan plus bevacizumab (NUFIRI-bev) to 5-FU/LV/irinotecan plus…NCT05678257·Newark, Delaware and 58 others

RecruitingA Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid MalignanciesThe goal of this study is to learn if KQB368 works to treat advanced solid malignancies in adults. The study will also learn about the safety of KQB368.NCT07542704·Los Angeles, California and 13 others

TerminatedFOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal CancerThe purpose of the Phase Ib portion is to find out the highest dose of study drug that can safely be given when tested in a small group of subjects.NCT01133990·Denver, Colorado and 33 others

CompletedS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well trastuzumab and pertuzumab work compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified…NCT03365882·Anchorage, Alaska and 797 others

CompletedComparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening StrategiesColorectal cancer (CRC) is the 2nd leading cause of cancer death in the US, though CRC death can be reduced by screening.NCT01710215·Dallas, Texas

TerminatedTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):This was a randomized, double-blind, placebo-controlled, global, multicenter, Phase 3 trial evaluating the impact of trilaciclib on myelopreservation and anti-tumor efficacy when…NCT04607668·Tucson, Arizona and 81 others

Active not recruitingFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsThis is a first time in-human (FTIH) study designed to investigate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of remzistotug in participants with select…NCT05277051·San Francisco, California and 25 others

Active not recruitingA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal CancerThis is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive…NCT04486378·Greenbrae, California and 84 others

TerminatedStudy of Personalized Immunotherapy in Adults With Metastatic Colorectal CancerThis study will evaluate the safety and tolerability of a personalized live, attenuated, double-deleted Listeria monocytogenes (pLADD) treatment in adults with metastatic…NCT03189030·Duarte, California and 4 others

CompletedCare Coordination for Complex Cancer Survivors in an Integrated Safety Net SystemNearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases…NCT02943265·Dallas, Texas

CompletedFluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00016198·Tucson, Arizona and 73 others

RecruitingA Phase 1 Study of IM-1617 in Participants With Advanced CancerThis study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors.NCT07578571·New Haven, Connecticut and 4 others

RecruitingA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerThis study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with metastatic KRAS G12D -…NCT07659795·Scottsdale, Arizona and 29 others

Active not recruitingAnti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)The purpose of this first in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors.NCT05464030·Encinitas, California and 34 others

PreviousPage 3 of 11Next

Other Conditions in Dallas

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma